A severe perioperative case supplied several lines of evidence for hypersensitivity after remimazolam. The report could not fully separate the molecular trigger or the contribution of spinal blockade.
The reported event
A 62-year-old woman developed chest discomfort, hypotension, and oxygen desaturation shortly after a remimazolam infusion during spinal anesthesia. Further anesthesia and resuscitation followed, including prolonged cardiopulmonary resuscitation and extracorporeal support.
Acute tryptase was higher than the later individual baseline. Skin testing four weeks later was positive for remimazolam and negative for several other administered agents. Those observations strengthened the authors’ attribution beyond timing alone.
What the evidence did not resolve
Because of the severe reaction, provocative re-exposure and some additional allergy tests were not performed. The authors could not formally distinguish an IgE-mediated reaction to the drug from a non-IgE reaction involving formulation components.
The relative contributions of spinal sympathetic blockade and anaphylaxis to the prolonged collapse remained uncertain. A descriptive collection of earlier cases also cannot supply an incidence denominator.
Use in a forensic assessment
Present the proposed causal mechanism at the level the evidence supports. Prior tolerance does not exclude later hypersensitivity, but a new collapse is not automatically allergic. Review the earliest symptoms, all exposures, testing, and alternative cardiovascular explanations rather than relying on the sedative’s usual hemodynamic reputation.
Source paper
Original analysis of the supplied journal article, identified as PMC13257691.
Leave a Reply